Skip to Main Content

Paper Details

Systematic Characterization of Antibody-Drug Conjugate Targets in Central Nervous System Tumors.
0
2023
ACP, ADC, AT, AT/, AT/RT, B7-H3, CD276, CLDN18, CLDN6, CNS tumors, Central Nervous System Tumors, Children's Brain Tumor, Ependymomas, Glioblastoma, HER2, HER3, NECTIN4, PCP, RNA, RNA-expression, RT, TROP2, Trastuzumab, adamantinomatous craniopharyngioma, atypical teratoid/rhabdoid tumor, brain metastases, cancers, central, central nervous system (CNS) tumors, ependymoma, glioblastoma, medulloblastoma, meningioma, meningiomas, metastatic breast cancer, oligodendroglioma, papillary craniopharyngioma, pilocytic astrocytoma, primary CNS lymphoma, solid and hematologic malignancies, tumors
Author NameAffiliation
Sanda AlexandrescuBoston Children's Hospital, Harvard Medical School
Patrick Y WenCenter for Neuro-Oncology, Dana-Farber Cancer Institute
Patrick Y WenBrigham and Women's Hospital
Peter K Sorger
Peter K SorgerHarvard Medical School
Keith L LigonBrigham and Women's Hospital
Keith L LigonCenter for Neuro-Oncology, Dana-Farber Cancer Institute
Keith L LigonBoston Children's Hospital, Harvard Medical School
Keith L Ligon
Keith L LigonDana-Farber Cancer Institute
Sandro SantagataBrigham and Women's Hospital
Sandro Santagata
Sandro SantagataHarvard Medical School
  • 1 - 13

Datasets